While CF is well-known for its impact on lung function and digestive processes, the increase in life expectancy with the introduction of new highly effective CFTR modulator (HEMT) therapy and recent evidence suggests a potential association between CF and an increased risk of developing certain types of cancers [4,5,6,7,8,9]. This evidence concerns the gene CFTR and cystic fibrosis.